Nicotine Science and Policy
By Harry Shapiro Aug. 13, 2026
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
November 20, 2026 by clearingtheair.eu
16 MEPs urge EU to ban vape flavours and disposables
Sixteen Members of the European Parliament are calling for an EU-wide ban on vape flavours and disposable e-cigarettes, alongside a freeze on new nicotine products.
The proposals aim to reduce youth appeal and address environmental concerns, but they do not assess the potential impact on adults who rely on flavoured vaping products to remain smoke-free.
As the EU prepares to revise its Tobacco Products Directive, the debate highlights the importance of balancing youth protection with tobacco harm reduction, while ensuring future regulation considers consumer behaviour and differences in product risk.
November 20, 2026 by vapingpost.com
Is Vaping as Harmful to Blood Vessels as Smoking? Yes, Says a Study… of 17 Vapers
A cardiovascular study involving just 17 vapers has drawn criticism from independent experts over claims that vaping may be as harmful to blood vessels as smoking.
Published in JAMA Cardiology, the research identified differences in vascular function but could not establish causation. Experts highlighted the small sample size, potential confounding factors and limitations of the study's comparisons.
The findings reinforce the need for larger, longitudinal studies and cautious interpretation of preliminary evidence, particularly when assessing the relative cardiovascular risks of vaping and combustible tobacco.
11.80% of the adult population are current smokers. There are approximately 6.7 million current smokers in United Kingdom 13.60% of men are current smokers but only 10.10% of women.
SOURCE: GSTHR
November 20, 2026 by gfn.tv
GFN.TV Interviews #98 | CRITICAL MASS | Global Safer Nicotine Use Reaches 200 Million
An estimated 200 million people worldwide now use safer nicotine products, according to the latest GSTHR Situation Report, with global vaping numbers nearly doubling over the past five years.
In the latest GFN.TV interview, economist Giorgi Mzhavanadze examines this growing transition, including evidence that smoke-free alternatives are increasingly replacing cigarettes in several countries.
However, rising use alone does not guarantee public health benefits. The key measure of tobacco harm reduction remains the number of people who successfully move away from combustible tobacco, supported by affordable access, consumer choice and proportionate regulation.
November 19, 2026 by pathtosmokefree.global
How Japan Halved Cigarette Sales and What It Means for the Rest of the World [Position Paper]
Japan's cigarette sales fell by 52.6% per capita between 2011 and 2023, with the decline accelerating following the nationwide introduction of heated tobacco products in 2016.
A new position paper estimates that 374 billion fewer cigarettes were consumed than previous trends would have predicted, highlighting the scale of Japan's transition towards smoke-free alternatives.
Japan's experience offers important lessons for tobacco harm reduction worldwide, demonstrating how consumer choice, product innovation and access to lower-risk alternatives can contribute to substantial changes in smoking behaviour.
November 19, 2026 by nzherald.co.nz
Smoking rate falls below 6% for first time, daily vaping declines slightly
New Zealand's daily smoking rate has fallen below 6% for the first time, reaching 5.9% in the latest national health survey, down from 6.7% the previous year. Daily vaping also declined slightly, from 11.7% to 11.2%.
The figures mark continued progress in reducing cigarette use, although smoking rates remain considerably higher among Māori and Pacific communities.
New Zealand's experience highlights the importance of maintaining effective cessation support and access to lower-risk nicotine alternatives, while addressing persistent inequalities in smoking-related harm.
- Page 1 of 46
Blogs
Harry's blog 134: Filtering out lies and misinformation
The only major global journal focused on harm reduction has gone bust. Since 2017, Filter has advocated through journalism for rational and compassionate approaches to drug use, drug policy and human rights, while also standing out for its coverage of tobacco harm reduction. Its closure is a significant loss - particularly at a time when well-funded opponents of tobacco harm reduction continue to thrive.
Harry’s blog 133: Silence is consent
Two tobacco control consultations that demand your attention
I’m sure there are many of you like me who are deeply cynical about public consultations. They often feel like political tick box exercises allowing the issuing authority from local councils to international organisations to say they have ‘consulted with the people’, when in truth they knew exactly what they were going to do from the get-go.
Harry’s Blog 132: “Zyn! Went The Strings Of My Heart” (with apologies to Judy Garland)
FDA approval of 20 nicotine pouch products is another step forward for tobacco harm reduction
The FDA in the U.S. has granted marketing authorisation for Zyn nicotine pouch products (five variations on mint plus five other flavours in two different strengths).
In its letter to PMI (who own Zyn manufacturers Swedish Match), the FDA wrote:
Based on our review of your MRTPAs [Modified Risk Tobacco Applications] we determined that the proposed modified risk tobacco products, …as actually used by consumers would significantly reduce harm and the risk of tobacco-related disease to individual tobacco users and benefit the health of the population as a whole, taking into account both users of tobacco products and persons who do not currently use tobacco products. Therefore, we authorize marketing of the tobacco products as modified risk tobacco products with the following modified risk information – “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis”.